"Levonorgestrel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
Descriptor ID |
D016912
|
MeSH Number(s) |
D04.210.500.668.651.693.762.450
|
Concept/Terms |
Levonorgestrel- Levonorgestrel
- l-Norgestrel
- l Norgestrel
- D-Norgestrel
- D Norgestrel
|
Below are MeSH descriptors whose meaning is more general than "Levonorgestrel".
Below are MeSH descriptors whose meaning is more specific than "Levonorgestrel".
This graph shows the total number of publications written about "Levonorgestrel" by people in this website by year, and whether "Levonorgestrel" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Levonorgestrel" by people in Profiles.
-
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 09 01; 140(3):477-487.
-
Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years. Contraception. 2021 06; 103(6):444-449.
-
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study. Cancer Prev Res (Phila). 2019 06; 12(6):401-412.
-
Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes. Fertil Steril. 2018 07 01; 110(1):83-88.
-
Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial. Contraception. 2014 Jun; 89(6):534-9.
-
Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception. 2012 Jun; 85(6):558-62.
-
Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A. Contraception. 2010 Feb; 81(2):123-7.
-
Emergency contraception: politics and science move forward. Obstet Gynecol. 2006 Nov; 108(5):1060-1.
-
Regarding Plan B: science and politics cannot be separated. Obstet Gynecol. 2005 May; 105(5 Pt 1):1148-50; author reply 1150-1.